Skip to content
Not evaluated by SAHPRA · Research & educational information only · Nothing on this site is for sale · Not medical advice · Consult a healthcare professional
Information only — not marketing · Not evaluated by SAHPRA · Consult a healthcare professional
← Back to Learn

The full peptides catalogue

Every research peptide in the library, grouped by what it does. Click through for full mechanism, dosing literature, and references.

Catalogue · Browse 31

Each card links to the entry with full benefits, mechanism, research-dose ranges, and the SAHPRA disclaimer. The structure images on each page come from Wikimedia Commons and PubChem; per-image attribution is in the docs/peptides/ markdown files.

Browse

Beauty

Energy

Hormone Balance

Mind & Mood

Performance

PerformanceResearch vial
CJC-1295 + Ipamorelin
10mg vial

CJC-1295 + Ipamorelin

A two-peptide blend pairing the GHRH analog CJC-1295 (without DAC / Modified GRF 1-29) with the selective ghrelin-receptor agonist Ipamorelin. CJC-1295 lifts the baseline of pulsatile GH release; Ipamorelin amplifies pulse amplitude without driving cortisol, prolactin or ACTH. Dual-receptor stimulation produces a GH response greater than the sum of either alone.

Read the research →
PerformanceResearch vial
Ipamorelin
5mg vial

Ipamorelin

Ipamorelin is a pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) and a selective agonist of the growth-hormone-secretagogue receptor (GHS-R1a) — the same receptor targeted by ghrelin. It triggers pulsatile GH release without the ACTH, cortisol and prolactin spikes seen with older GHRPs (GHRP-2, GHRP-6, hexarelin).

Read the research →
PerformanceResearch vial
Hexarelin
5mg vial

Hexarelin

Hexarelin is a synthetic hexapeptide analog of GHRP-6 and a potent agonist of the growth-hormone-secretagogue receptor (GHS-R1a). It also binds the non-GHS-R receptor CD36, which underlies a separate cardiac action that does not depend on GH release. Of the older GHRPs it produces the strongest GH pulse.

Read the research →
PerformanceResearch vial
IGF-1 LR3
1mg vial

IGF-1 LR3

IGF-1 LR3 (Long R3 IGF-1) is an 83-amino-acid synthetic analog of insulin-like growth factor 1 with a 13-residue N-terminal extension and an arginine substituted for glutamic acid at position 3. The Arg-3 substitution drops affinity for IGF binding proteins ~100-fold while preserving full IGF-1 receptor agonism, so more of the injected peptide is free to bind tissue.

Read the research →
PerformanceResearch vial
Amino-1MQ
10mg vial

Amino-1MQ

5-amino-1-methylquinolinium (5-Amino-1MQ) is a selective small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT). NNMT methylates nicotinamide into 1-methylnicotinamide, consuming both NAD+ precursors and methyl donors. Inhibiting it raises intracellular NAD+ and SAM, and in adipocytes it suppresses lipogenesis.

Read the research →

Recovery

RecoveryResearch vial
KLOW
80mg vial

KLOW

A proprietary four-peptide research blend most commonly formulated as GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg + KPV 10mg per 80mg vial. Covers collagen and matrix remodelling, angiogenesis, cell migration, and NF-kB-driven inflammation in a single stack.

Read the research →
RecoveryResearch vial
Wolfstack
20mg vial

Wolfstack

A Wolverine-style recovery blend, typically BPC-157 10mg + TB-500 10mg per 20mg vial. Pairs local repair signalling with systemic progenitor-cell mobilisation for muscle, tendon, ligament and gut injury work.

Read the research →
RecoveryResearch vial
BPC-157
10mg vial

BPC-157

Body Protection Compound-157, a synthetic 15-amino-acid pentadecapeptide derived from a sequence in human gastric juice. Acts on multiple repair pathways - angiogenesis, nitric oxide signalling, and growth-factor expression - rather than a single receptor.

Read the research →
RecoveryResearch vial
PEG-MGF
2mg vial

PEG-MGF

Pegylated Mechano Growth Factor - a 24-amino-acid C-terminal splice variant of IGF-1 (IGF-1Ec) expressed by skeletal muscle in response to mechanical load. The PEG chain extends a half-life of minutes into hours, allowing systemic dosing.

Read the research →
RecoveryResearch vial
KPV
10mg vial

KPV

A lysine-proline-valine tripeptide corresponding to the C-terminal fragment of alpha-MSH. Acts independently of melanocortin receptors - its anti-inflammatory effect is mediated by uptake through the PepT1 transporter on intestinal epithelial and immune cells.

Read the research →

Weight Loss